For 20 years, the Knight Alzheimer Disease Research Center has worked to boost diversity in clinical trials.
Alzheimer’s disease is like two deaths, said Stephanie Griffin, whose father died of the brain disease in 2015. “It’s horrific,” she said. “First, you watch them lose the ability to talk, to think, to do any of the things they used to do. And then, to see them pass because of it? It’s just … it’s a lot.”